Massive Genentech facility in Bay Area acquired by Swiss company for $1.2 billion
-----
A Swiss firm has acquired the expansive Genentech manufacturing facility in Vacaville, which was listed last summer.Lonza has agreed to buy the property from Roche Holding AG, the parent company of the biotechnology firm, for approximately $1.2 billion in cash. Additionally, Lonza plans to invest $1.38 million in upgrades.
The Bay Area facility is considered one of the world's largest sites for biologics manufacturing.
Roche announced in May that it would sell its drug
